Hsu J - Search Results

1

Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J; Wills Post Injection Endophthalmitis (PIE) Study Group. Borkar DS, et al. Among authors: hsu j. Am J Ophthalmol. 2018 Oct;194:1-6. doi: 10.1016/j.ajo.2018.06.022. Epub 2018 Jul 6. Am J Ophthalmol. 2018. PMID: 29981738

2

Retinal pigment epithelial tear after intravitreal bevacizumab injection.

Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R. Shah CP, et al. Among authors: hsu j. Am J Ophthalmol. 2006 Dec;142(6):1070-2. doi: 10.1016/j.ajo.2006.07.037. Epub 2006 Sep 12. Am J Ophthalmol. 2006. PMID: 17157598

3

Optical coherence tomography findings in acute retinal pigment epitheliitis.

Hsu J, Fineman MS, Kaiser RS. Hsu J, et al. Am J Ophthalmol. 2007 Jan;143(1):163-5. doi: 10.1016/j.ajo.2006.07.052. Epub 2006 Aug 31. Am J Ophthalmol. 2007. PMID: 17188058

4

Drug delivery methods for posterior segment disease.

Hsu J. Hsu J. Curr Opin Ophthalmol. 2007 May;18(3):235-9. doi: 10.1097/ICU.0b013e3281108000. Curr Opin Ophthalmol. 2007. PMID: 17435432 Review.

5

Intravitreal bevacizumab (avastin) in central retinal vein occlusion.

Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC. Hsu J, et al. Retina. 2007 Oct;27(8):1013-9. doi: 10.1097/IAE.0b013e318050ca7c. Retina. 2007. PMID: 18040237

6

Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes.

Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD. Hsu J, et al. Retina. 2008 Jul-Aug;28(7):937-40. doi: 10.1097/IAE.0b013e31816c6855. Retina. 2008. PMID: 18698294

7

Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema.

Chen E, Hsu J, Park CH. Chen E, et al. Among authors: hsu j. Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):68-70. doi: 10.3928/15428877-20090101-04. Ophthalmic Surg Lasers Imaging. 2009. PMID: 19205502

8

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

CATT Research Group; Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. CATT Research Group, et al. N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.

9

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team. Shah CP, et al. Ophthalmology. 2011 Oct;118(10):2028-34. doi: 10.1016/j.ophtha.2011.02.034. Epub 2011 Jun 25. Ophthalmology. 2011. PMID: 21705087

10

Psychological and cognitive determinants of vision function in age-related macular degeneration.

Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS; Wills Eye AMD Study. Rovner BW, et al. Arch Ophthalmol. 2011 Jul;129(7):885-90. doi: 10.1001/archophthalmol.2011.146. Arch Ophthalmol. 2011. PMID: 21746979 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,012 results

Search Page

Filters